CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a targeted drug make stem cell transplants more effective for tough blood cancers?
Disease control OngoingThis early-phase trial is testing whether adding the drug venetoclax to standard chemotherapy before and after a bone marrow transplant can help prevent cancer from coming back in people with high-risk acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or related blood…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE1 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for rare leukemia: targeted pill shows promise in early trial
Disease control OngoingThis study tests a drug called cobimetinib in people with a rare blood cancer (CMML) that has certain gene mutations. The goal is to see if the drug can shrink or control the cancer. Fourteen adults with either new or treatment-resistant CMML will take the drug daily in 3-week-on…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC